This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

Due to the nature of any test requiring blood draws, all risks and associated costs incurred to schedule and arrange phlebotomy are for the clients account.  Should a sample be rejected or fail for any reason whatsoever, Nordic Laboratories are not responsible for additional costs incurred to procure a replacement sample.  No liability will pass to, or be accepted by Nordic Laboratories.

By ordering this test, you accept these inherent risks and any costs incurred, understanding that no recourse or compensation will apply for any costs incurred.

Practical

Specimen

Whole blood 

Container

• 1 x 2 ml SST tube (yellow colour cap) 
• 2 x EDTA tubes (purple colour cap) 
• 1 x 8 ml DCG tube

Volume

17 mL

Patient preparation

The patient must not have received any form of cancer therapy (radiation / chemo-therapy / surgery / endocrine therapy etc.) at least 15 days prior to collection of sample.
The patient must not have received oral or IV corticosteroids at least 15 days prior to collection of sample.
Patient has no current febrile or any other acute inflammatory illness.
Patient does not have acute exacerbation or flare-up of an inflammatory condition requiring escalation in medical therapy at least 5 days prior to collection of sample.
Patient has not received blood transfusion / PET-CT / CT scan at least 5 days prior to collection of sample.
Patient is not positive for HIV / HBV / HCV.